Literature DB >> 2171672

Binding of platelet activating factor to albumin.

K L Clay1, C Johnson, P Henson.   

Abstract

Binding of platelet activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) to albumin is an important facet of the biological activity of this phospholipid. Measurement of that binding has been hampered by the physical nature of the lipid, which made estimation of the free and bound concentrations difficult. With the use of ultracentrifugation to generate an albumin gradient and to produce a region free of protein, the successful measurement of free PAF and PAF bound to albumin was accomplished. This study has demonstrated that PAF binds to albumin at four binding sites and that the average equilibrium dissociation constant for this binding is 1.10(-7) M. Consideration of these data has led to the hypothesis that the receptor active form of PAF is the albumin-PAF complex, rather than free PAF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171672     DOI: 10.1016/0005-2760(90)90246-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.

Authors:  Jinbo Liu; Rui Chen; Gopal K Marathe; Maria Febbraio; Weilin Zou; Thomas M McIntyre
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

Review 2.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

3.  Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.

Authors:  J T O'Flaherty; D P Jacobson; J F Redman
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.

Authors:  G Grigoriadis; A G Stewart
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

6.  Febrigenic signaling to the brain does not involve nitric oxide.

Authors:  Alexandre A Steiner; Alla Y Rudaya; Andrei I Ivanov; Andrej A Romanovsky
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

7.  Oxidative stress mediated platelet activation in patients with congenital analbuminemia: Effect of albumin infusion.

Authors:  Francesco Baratta; Simona Bartimoccia; Roberto Carnevale; Lucia Stefanini; Francesco Angelico; Maria Del Ben
Journal:  J Thromb Haemost       Date:  2021-10-16       Impact factor: 16.036

8.  Anticoagulant action of low, physiologic, and high albumin levels in whole blood.

Authors:  Margret Paar; Christine Rossmann; Christoph Nusshold; Thomas Wagner; Axel Schlagenhauf; Bettina Leschnik; Karl Oettl; Martin Koestenberger; Gerhard Cvirn; Seth Hallström
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.